TO Title: Contract Orientation & Kickoff Meeting for Preclinical Services for PREVENTBase IDIQ Title: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate End

NIH RePORTER · NIH · N01 · $3,500 · view on reporter.nih.gov ↗

Abstract

PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.

Key facts

NIH application ID: 11020345
Project number: 75N91024D00004-0-759102400001-1
Recipient: UNIVERSITY OF TX MD ANDERSON CAN CTR
Principal Investigator: Eduardo Vilar Sanchez
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $3,500
Award type: —
Project period: 2024-01-25 → 2029-01-24